Department of Surgery, University of Alberta Hospital, Edmonton, AB, T6G 2G4, Canada.
Institute for Reconstructive Sciences in Medicine (iRSM), Misericordia Community Hospital, Edmonton, AB, Canada.
J Otolaryngol Head Neck Surg. 2017 Sep 4;46(1):56. doi: 10.1186/s40463-017-0234-y.
While aggressive treatment for oral cancer may optimize survival, decrements in speech and swallowing function and quality of life often result. This exploratory study investigated how patients recover their communicative function, swallowing ability, and quality of life after primary surgery [with or without adjuvant (chemo)radiation therapy] for tongue cancer over the course of the first year post-operation.
Patients treated for oral cancer at three institutions (University of Alberta Hospital, Mount Sinai Beth Israel Medical Center, and Turku University Hospital) were administered patient-reported outcomes assessing speech [Speech Handicap Index (SHI)], swallowing [(M.D. Anderson Dysphagia Inventory (MDADI)] and quality of life [European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module (EORTC-H&N35)]. Outcome measures were completed pre-operatively and at 1-, 6-, and 12-months post-operatively.
One hundred and seventeen patients undergoing partial glossectomy with reconstruction participated in this study. Results indicated no significant differences in swallowing function (MDADI and EORTC-H&N35 subscales) between baseline and 6 months post-surgery and no significant differences in speech function (SHI subscales) between baseline and 1 year post-surgery. Most quality of life domains (EORTC-H&N35 subscales) returned to baseline levels by 1 year post-operation, while difficulties with dry mouth and sticky saliva persisted. A clear time trend of adjuvant (chemo)radiation therapy negatively affecting dry mouth scores over time was identified in this study, while negative independent effects of chemoradiation on MDADI swallowing, and EORTC-H&N35 swallowing, eating, and opening mouth subscales were found.
Assessment time influenced patient-reported speech, swallowing, and quality of life outcomes, while treatment (by time) effects were found for only swallowing and quality of life outcomes. Results of the present study will help guide clinical care and will be useful for patient counseling on expected short and long-term functional and quality of life outcomes of surgical and adjuvant treatment for oral cavity cancer.
尽管积极治疗口腔癌可以提高生存率,但通常会导致言语和吞咽功能以及生活质量下降。本探索性研究调查了舌癌患者在接受原发性手术后(是否有辅助[放化疗]),在术后第一年的过程中如何恢复其沟通功能、吞咽能力和生活质量。
在三个机构(阿尔伯塔大学医院、西奈山贝斯以色列医疗中心和图尔库大学医院)接受口腔癌治疗的患者接受了患者报告的结果评估,评估了言语[言语障碍指数(SHI)]、吞咽[(MD 安德森吞咽障碍指数(MDADI)]和生活质量[欧洲癌症研究与治疗组织生活质量问卷头颈部模块(EORTC-H&N35)]。在术前和术后 1、6 和 12 个月完成了结果测量。
117 名接受部分舌切除术和重建的患者参与了这项研究。结果表明,在手术后 6 个月,吞咽功能(MDADI 和 EORTC-H&N35 子量表)与基线相比没有显著差异,手术后 1 年,言语功能(SHI 子量表)与基线相比没有显著差异。大多数生活质量领域(EORTC-H&N35 子量表)在术后 1 年时恢复到基线水平,而口干和粘唾液的困难仍然存在。本研究中确定了辅助(放化疗)治疗随时间推移对口干评分的负面影响的明确时间趋势,而放化疗对 MDADI 吞咽、EORTC-H&N35 吞咽、进食和张口子量表的独立负效应也得到了证实。
评估时间影响了患者报告的言语、吞咽和生活质量结果,而治疗(随时间)仅对吞咽和生活质量结果有影响。本研究的结果将有助于指导临床护理,并将对口腔癌手术和辅助治疗的短期和长期功能和生活质量结果的患者咨询有用。